Ledger.Open graph →
SEC Form D · filed February 6, 2014

Pulse Therapeutics, Inc

Offering
$1.5M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ST. LOUIS, MO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Peggy A. Stohr · St. Louis, MOExecSean A. Morris · St. Louis, MOExecBevil J. Hogg · St. Louis, MODirectorThomas J. Hillman · St. Louis, MODirectorEric A. Gulve · St. Louis, MODirectorFrancis M. Creighton · St. Louis, MOExec · DirectorStephen A. Wexler · St. Louis, MODirectorEric A. Gulve · St. Louis, MODirectorPeggy A. Stohr · St. Louis, MOExecSean A. Morris · St. Louis, MOExecBevil J. Hogg · LEESBURG, VADirectorFrancis M. Creighton · St. Louis, MOExec · DirectorThomas J. Hillman · St. Louis, MODirectorStephen A. Wexler · St. Louis, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗